Adrien J
INSERM U288, CHU Pitié-Salpêtrière, 91, Bd de l'Hôpital, 75013 Paris.
Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S7-11.
Sleepiness increases with duration of sleep deprivation. Rebound sleep together with enhancement of slow wave activity are characteristic of the subsequent recovery period. These homeostatic properties of the regulation of sleep-wakefulness are mediated by central adenosinergic modulations. The involvement of adenosine in sleep processes has been known for a long time, as illustrated by the fact that blockade of adenosine receptors by caffeine promotes wakefulness. However, its mechanisms of action in these processes have only recently been thoroughly investigated, notably by use of microdialysis techniques in free-moving animals. In the central nervous system, adenosine acts as a neurotransmitter, but it is not released from synaptic vesicles in specific neurons. Adenosine is synthesized in neurons and glial cells and is released into the extracellular space when energy expenditure exceeds energy production. Adenosine acts at A1 receptors to inhibit target transmitter release and to hyperpolarize neurons, and at A2A receptors, possibly activating GABAergic inhibitory systems. Extracellular concentrations of adenosine in most brain areas are deceased during sleep compared to wakefulness, but these modifications are linked to sleep regulatory mechanisms, essentially in the basal forebrain. In the basal forebrain and in the cortex, adenosine levels are considerably enhanced during sustained prolonged wakefulness and decrease progressively during the recovery period. This enhancement of adenosine concentration would be responsible for sleep rebound and for slow wave activity observed after sleep deprivation, since these effects are mimicked by infusion of A1 agonists into the basal forebrain and are counteracted by treatment with adenosinergic antagonists such as caffeine or theophylline. The action of adenosine on sleep-wakefulness regulation would be accounted for by an inhibitory influence on wakefulness-promoting cholinergic neurons of the basal forebrain and the mesopontine area, and by facilitation of sleep-related neurons in the hypothalamic preoptic nucleus. Through these mechanisms, adenosine would be, more than a sleep modular, a homeostatic signal regulating sleepiness and sleep rebound, which are both associated with prolonged wakefulness.
睡眠剥夺的持续时间越长,困倦感越强。随后的恢复期的特征是出现反弹睡眠以及慢波活动增强。睡眠 - 觉醒调节的这些稳态特性是由中枢腺苷能调节介导的。腺苷参与睡眠过程已为人所知甚久,例如咖啡因阻断腺苷受体会促进觉醒这一事实就说明了这一点。然而,其在这些过程中的作用机制直到最近才得到深入研究,尤其是通过在自由活动动物中使用微透析技术进行研究。在中枢神经系统中,腺苷作为一种神经递质起作用,但它不是从特定神经元的突触小泡中释放出来的。腺苷在神经元和神经胶质细胞中合成,当能量消耗超过能量产生时释放到细胞外空间。腺苷作用于A1受体以抑制靶递质释放并使神经元超极化,作用于A2A受体时可能激活GABA能抑制系统。与清醒状态相比,大多数脑区的细胞外腺苷浓度在睡眠期间会降低,但这些变化与睡眠调节机制有关,主要是在基底前脑。在基底前脑和皮层中,在持续长时间觉醒期间腺苷水平会显著升高,而在恢复期会逐渐降低。腺苷浓度的这种升高可能是睡眠剥夺后出现的睡眠反弹和慢波活动的原因,因为将A1激动剂注入基底前脑可模拟这些效应,而咖啡因或茶碱等腺苷能拮抗剂的治疗可抵消这些效应。腺苷对睡眠 - 觉醒调节的作用可能是通过对基底前脑和中脑桥脑区域促进觉醒的胆碱能神经元产生抑制作用,以及通过促进下丘脑视前核中与睡眠相关的神经元来实现的。通过这些机制,腺苷不仅仅是一个睡眠调节因子,更是一个调节困倦感和睡眠反弹的稳态信号,而困倦感和睡眠反弹都与长时间觉醒有关。